ORAMED PHARMACEUTICALS INC. Quarterly Operating Lease, Right-of-Use Asset in USD from Q3 2019 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Oramed Pharmaceuticals Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q3 2019 to Q3 2024.
  • Oramed Pharmaceuticals Inc. Operating Lease, Right-of-Use Asset for the quarter ending September 30, 2024 was $486K, a 36.7% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $486K -$282K -36.7% Sep 30, 2024 10-Q 2024-11-07
Q2 2024 $566K -$276K -32.8% Jun 30, 2024 10-Q 2024-08-14
Q1 2024 $608K -$307K -33.6% Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $694K -$293K -29.7% Dec 31, 2023 10-Q 2024-11-07
Q3 2023 $768K -$237K -23.6% Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $842K -$234K -21.7% Jun 30, 2023 10-Q 2023-08-10
Q1 2023 $915K -$193K -17.4% Mar 31, 2023 10-Q 2023-05-11
Q4 2022 $987K +$487K +97.4% Dec 31, 2022 10-K 2024-03-06
Q3 2022 $1.01M +$472K +88.6% Sep 30, 2022 10-Q 2022-11-10
Q2 2022 $1.08M +$516K +92.1% Jun 30, 2022 10-Q 2022-08-10
Q1 2022 $1.11M +$500K +82.2% Mar 31, 2022 10-Q 2022-05-12
Q4 2021 $500K -$140K -21.9% Dec 31, 2021 10-K 2023-03-06
Q3 2021 $533K +$458K +611% Aug 31, 2021 10-QT 2022-03-30
Q2 2021 $560K +$471K +529% May 31, 2021 10-Q 2021-07-14
Q1 2021 $608K +$509K +514% Feb 28, 2021 10-Q 2021-04-13
Q4 2020 $640K +$534K +504% Nov 30, 2020 10-Q 2021-01-14
Q3 2020 $75K -$93K -55.4% Aug 31, 2020 10-K 2021-11-24
Q2 2020 $89K May 31, 2020 10-Q 2020-07-07
Q1 2020 $99K Feb 29, 2020 10-Q 2020-04-06
Q4 2019 $106K Nov 30, 2019 10-Q 2020-01-09
Q3 2019 $168K Sep 1, 2019 10-Q 2021-04-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.